BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND PSA AND Treatment
40 results:

  • 1.
    Kim SY; Park JE; Lee HJ; Sim DY; Ahn CH; Park SY; Shim BS; Kim B; Lee DY; Kim SH
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474045
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cost-effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for the treatment of 3L + relapsed/refractory large B-cell lymphoma in the United States: incorporating longer survival results.
    Oluwole OO; Ray MD; Davies N; Bradford R; Jones C; Patel AR; Locke FL
    J Med Econ; 2024; 27(1):230-239. PubMed ID: 38240256
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prophylaxis for
    Huang X; Huang X; Lin S; Luo S; Dong L; Lin D; Huang Y; Xie C; Nian D; Xu X; Weng X
    BMJ Open; 2023 Mar; 13(3):e068943. PubMed ID: 36972963
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States.
    Shah BD; Smith NJ; Feng C; Jeyakumar S; Castaigne JG; Faghmous I; Masouleh BK; Malone DC; Bishop MR
    Adv Ther; 2022 Aug; 39(8):3678-3695. PubMed ID: 35727476
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cost-effectiveness and value of information analyses of Bruton's tyrosine kinase inhibitors in the treatment of relapsed or refractory mantle cell lymphoma in the United States.
    Alrawashdh N; McBride A; Slack M; Persky D; Andritsos L; Abraham I
    J Manag Care Spec Pharm; 2022 Apr; 28(4):390-400. PubMed ID: 35332792
    [No Abstract]    [Full Text] [Related]  

  • 6. Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
    Husni ME; Deodhar A; Schwartzman S; Chakravarty SD; Hsia EC; Leu JH; Zhou Y; Lo KH; Kavanaugh A
    Arthritis Res Ther; 2022 Mar; 24(1):73. PubMed ID: 35313978
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Cost effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy in the United States.
    Liu R; Oluwole OO; Diakite I; Botteman MF; Snider JT; Locke FL
    J Med Econ; 2021; 24(1):458-468. PubMed ID: 33691581
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Protective effects of combination of Stauntonia hexaphylla and Cornus officinalis on testosterone-induced benign prostatic hyperplasia through inhibition of 5α- reductase type 2 and induced cell apoptosis.
    Karunasagara S; Hong GL; Jung DY; Kim KH; Cho K; Jung JY
    PLoS One; 2020; 15(8):e0236879. PubMed ID: 32790676
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Pharmacological inhibition of androgen receptor expression induces cell death in prostate cancer cells.
    Song IS; Jeong YJ; Kim J; Seo KH; Baek NI; Kim Y; Kim CS; Jang SW
    Cell Mol Life Sci; 2020 Nov; 77(22):4663-4673. PubMed ID: 31894360
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia.
    Rambaldi A; Ribera JM; Kantarjian HM; Dombret H; Ottmann OG; Stein AS; Tuglus CA; Zhao X; Kim C; Martinelli G
    Cancer; 2020 Jan; 126(2):304-310. PubMed ID: 31626339
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Incidental Finding of Acute Lymphocytic Leukemia in a Prostate-Specific Membrane Antigen PET/CT.
    Acksteiner C; Sounness B
    Clin Nucl Med; 2019 Sep; 44(9):e529-e531. PubMed ID: 31306192
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Primary prostate lymphoma: A case report and literature review.
    Wang K; Wang N; Sun J; Fan Y; Chen L
    Int J Immunopathol Pharmacol; 2019; 33():2058738419863217. PubMed ID: 31280618
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial.
    Foeldvari I; Constantin T; Vojinović J; Horneff G; Chasnyk V; Dehoorne J; Panaviene V; Sušić G; Stanevicha V; Kobusinska K; Zuber Z; Dobrzyniecka B; Nikishina I; Bader-Meunier B; Breda L; Doležalová P; Job-Deslandre C; Rumba-Rozenfelde I; Wulffraat N; Pedersen RD; Bukowski JF; Vlahos B; Martini A; Ruperto N;
    Arthritis Res Ther; 2019 May; 21(1):125. PubMed ID: 31122296
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Cost-effectiveness analysis of rasburicase over standard of care for the prevention and treatment of tumor lysis syndrome in children with hematologic malignancies in China.
    Hu S; Han Y; Zhang W; Zhang T; Yao X; Liu L
    J Med Econ; 2019 Aug; 22(8):742-750. PubMed ID: 30939962
    [No Abstract]    [Full Text] [Related]  

  • 15. Successful treatment of concomitant metastatic prostate cancer and B-cell non-Hodgkin's lymphoma with R-EPOCH chemotherapy regimen and antiandrogen therapy.
    Hanna F; Prakash A; Allan E; Khalafallah AA
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29549134
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Quisqualis indica Improves Benign Prostatic Hyperplasia by Regulating Prostate Cell Proliferation and Apoptosis.
    Ub Wijerathne C; Park HS; Jeong HY; Song JW; Moon OS; Seo YW; Won YS; Son HY; Lim JH; Yeon SH; Kwun HJ
    Biol Pharm Bull; 2017 Dec; 40(12):2125-2133. PubMed ID: 28943529
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The cost-effectiveness of alectinib in anaplastic lymphoma kinase-positive (ALK+) advanced NSCLC previously treated with crizotinib.
    Carlson JJ; Canestaro W; Ravelo A; Wong W
    J Med Econ; 2017 Jul; 20(7):671-677. PubMed ID: 28332433
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Androgen receptor expression in mantle cell lymphoma: Potential novel therapeutic implications.
    Mostaghel EA; Martin PS; Mongovin S; Frayo S; Zhang A; Edlefsen KL; Press OW; Gopal AK
    Exp Hematol; 2017 May; 49():34-38.e2. PubMed ID: 28115200
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Synchronous mantle cell lymphoma and prostate adenocarcinoma-is it just a coincidence?
    Petković I; Stojnev S; Krstić M; Pejčić I; Vrbić S
    Vojnosanit Pregl; 2016 Nov; 73(11):1072-5. PubMed ID: 29341562
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers.
    Hellgren K; Dreyer L; Arkema EV; Glintborg B; Jacobsson LT; Kristensen LE; Feltelius N; Hetland ML; Askling J;
    Ann Rheum Dis; 2017 Jan; 76(1):105-111. PubMed ID: 27147709
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.